Breaking News Instant updates and real-time market news.

ARGX

Argenx

$30.45

0.05 (0.16%)

11:55
12/11/17
12/11
11:55
12/11/17
11:55

Argenx to hold a workshop

Management holds a workshop, which is being held in conjunction with the American Society of Hematology (ASH) 59th Annual Meeting, to provide an update on the Phase 1/2 clinical trials of ARGX-110 in acute myeloid leukemia and cutaneous T-cell lymphoma (CTCL) on December 11 at 12 pm. Webcast Link

  • 11

    Dec

  • 11

    Dec

ARGX Argenx
$30.45

0.05 (0.16%)

11/16/17
WEDB
11/16/17
NO CHANGE
Target $41
WEDB
Outperform
Argenx price target raised to $41 from $26 at Wedbush
Wedbush analyst David Nierengarten raised his price target for Argenx to $41 from $26 as he incorporates the pemphigus vulgaris market opportunity into his valuation. The analyst reiterates an Outperform rating on the shares.
10/24/17
PIPR
10/24/17
NO CHANGE
Target $32
PIPR
Overweight
Argenx drug has differentiated mechanism to treat MG, says Piper Jaffray
After news that the FDA approved an expanded label for Alexion's (ALXN) Soliris to treat generalized Myasthenia Gravis, or gMG, Piper Jaffray analyst Edward Tenthoff said that while this is a significant milestone he still sees room for new therapies. He believes that Argenx's (ARGX) ARGX-113 has a differentiated mechanism to treat MG and notes it is scheduled to report Phase 2 data on the drug in that indication in the first quarter of 2018. Tenthoff reiterates his Overweight rating and $32 price target on Argenx shares, which are down nearly 4% to $19.42 in morning trading.
06/12/17
JMPS
06/12/17
INITIATION
JMPS
Outperform
Argenx initiated with an Outperform at JMP Securities
JMP Securities analyst Michael King started coverage of Argenx with a $33 price target and an Outperform rating. He says that the company's technology gives it "profound competitive advantages over other antibody companies." Target $33.
06/12/17
PIPR
06/12/17
NO CHANGE
Target $32
PIPR
Overweight
Argenx transitioned with an Overweight at Piper Jaffray
Following the company's Nasdaq IPO, Piper Jaffray transitioned coverage of Argenx to analyst Edward Tenthoff with an Overweight rating and $32 price target.

TODAY'S FREE FLY STORIES

TXT

Textron

$66.80

0.13 (0.19%)

09:49
07/17/18
07/17
09:49
07/17/18
09:49
Technical Analysis
Technical Earnings Preview: Textron near highs before news »

The stock is in a strong…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

GS

Goldman Sachs

$230.50

-0.51 (-0.22%)

09:48
07/17/18
07/17
09:48
07/17/18
09:48
Hot Stocks
Goldman Sachs CFO says investment banking backlog reached record in Q2 »

Goldman Sachs CFO Marty…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:48
07/17/18
07/17
09:48
07/17/18
09:48
Conference/Events
Cowen Internet & new media analyst to hold an analyst/industry conference call »

Internet & New Media…

09:47
07/17/18
07/17
09:47
07/17/18
09:47
General news
Netflix slide leading Nasdaq to struggle at open »

Stock futures fell during…

SERV

ServiceMaster

$61.85

(0.00%)

09:47
07/17/18
07/17
09:47
07/17/18
09:47
Hot Stocks
ServiceMaster falls -5.7% »

ServiceMaster is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

HZN

Horizon Global

$6.89

(0.00%)

09:47
07/17/18
07/17
09:47
07/17/18
09:47
Hot Stocks
Horizon Global falls -6.6% »

Horizon Global is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OMC

Omnicom

$72.81

-5.31 (-6.80%)

09:47
07/17/18
07/17
09:47
07/17/18
09:47
Hot Stocks
Omnicom falls -6.9% »

Omnicom is down -6.9%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 09

    Aug

IGT

International Game

$25.17

0.78 (3.20%)

09:47
07/17/18
07/17
09:47
07/17/18
09:47
Hot Stocks
International Game rises 3.5% »

International Game is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

GOL

Gol Linhas

$6.66

0.27 (4.23%)

09:47
07/17/18
07/17
09:47
07/17/18
09:47
Hot Stocks
Gol Linhas rises 3.8% »

Gol Linhas is up 3.8%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FPI

Farmland Partners

$6.54

0.445 (7.30%)

09:47
07/17/18
07/17
09:47
07/17/18
09:47
Hot Stocks
Farmland Partners rises 7.0% »

Farmland Partners is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CATM

Cardtronics

$26.60

(0.00%)

09:46
07/17/18
07/17
09:46
07/17/18
09:46
Recommendations
Cardtronics analyst commentary  »

Cardtronics immediate…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

09:45
07/17/18
07/17
09:45
07/17/18
09:45
General news
Housing Market Index to be reported at 10:00 »

July Housing Market Index…

09:45
07/17/18
07/17
09:45
07/17/18
09:45
General news
Breaking General news story  »

Federal Reserve Chairman…

CMCSA

Comcast

$34.98

(0.00%)

, CMCSK

Comcast

$0.00

(0.00%)

09:42
07/17/18
07/17
09:42
07/17/18
09:42
Periodicals
NBCU relaunches Craftsy as subscription-video service Bluprint, Variety reports »

NBCUniversal Cable…

CMCSA

Comcast

$34.98

(0.00%)

CMCSK

Comcast

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$124.70

(0.00%)

09:42
07/17/18
07/17
09:42
07/17/18
09:42
Hot Stocks
Johnson & Johnson says 'disappointed' in Spine & Knee medical sales results »

Says Spine still an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 08

    Aug

BA

Boeing

$356.01

(0.00%)

09:41
07/17/18
07/17
09:41
07/17/18
09:41
Hot Stocks
Boeing, Xiamen Airlines announce optimized maintenance program deal »

Boeing and Xiamen…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

SNA

Snap-On

$163.93

(0.00%)

09:41
07/17/18
07/17
09:41
07/17/18
09:41
Recommendations
Snap-On analyst commentary  »

Snap-On checks point to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 16

    Aug

VEON

Veon

$3.05

(0.00%)

, HFC

HollyFrontier

$68.91

(0.00%)

09:40
07/17/18
07/17
09:40
07/17/18
09:40
Options
Unusually active option classes on open July 17th »

Unusual total active…

VEON

Veon

$3.05

(0.00%)

HFC

HollyFrontier

$68.91

(0.00%)

DUST

Direxion Daily Gold Miners Bear 3X ETF

$25.49

(0.00%)

UNH

UnitedHealth

$257.03

(0.00%)

JNJ

Johnson & Johnson

$124.70

(0.00%)

CZR

Caesars

$11.63

(0.00%)

GS

Goldman Sachs

$231.01

(0.00%)

MCD

McDonald's

$158.76

(0.00%)

ATVI

Activision Blizzard

$80.23

(0.00%)

GDX

Market Vector Gold Miners

$21.88

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 17

    Jul

  • 01

    Aug

  • 02

    Aug

  • 02

    Aug

  • 08

    Aug

NFLX

Netflix

$400.24

4.32 (1.09%)

09:38
07/17/18
07/17
09:38
07/17/18
09:38
Recommendations
Netflix analyst commentary  »

Netflix Q2 weakness is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WEX

Wex

$194.01

-2 (-1.02%)

09:36
07/17/18
07/17
09:36
07/17/18
09:36
Initiation
Wex initiated  »

Wex initiated with a Peer…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GS

Goldman Sachs

$231.01

4.71 (2.08%)

09:36
07/17/18
07/17
09:36
07/17/18
09:36
Periodicals
Lloyd Blankfein writes farewell memo to Goldman Sachs team, NY Times reports »

Goldman Sachs CEO LLoyd…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVRO

Nevro

$58.79

1.04 (1.80%)

09:35
07/17/18
07/17
09:35
07/17/18
09:35
Recommendations
Nevro analyst commentary  »

Nevro price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

FLT

FleetCor

$216.11

-4.06 (-1.84%)

09:35
07/17/18
07/17
09:35
07/17/18
09:35
Initiation
FleetCor initiated  »

FleetCor initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SQ

Square

$66.95

-0.06 (-0.09%)

09:35
07/17/18
07/17
09:35
07/17/18
09:35
Initiation
Square initiated  »

Square initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

  • 15

    Aug

  • 16

    Aug

FIS

FIS

$107.72

-0.45 (-0.42%)

09:35
07/17/18
07/17
09:35
07/17/18
09:35
Initiation
FIS initiated  »

FIS initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.